[HTML][HTML] CD49d is the strongest flow cytometry–based predictor of overall survival in chronic lymphocytic leukemia
P Bulian, TD Shanafelt, C Fegan… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
P Bulian, TD Shanafelt, C Fegan, A Zucchetto, L Cro, H Nückel, L Baldini, AV Kurtova…
Journal of Clinical Oncology, 2014•ncbi.nlm.nih.govPurpose Although CD49d is an unfavorable prognostic marker in chronic lymphocytic
leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis
was performed using published and unpublished CLL series to evaluate the impact of
CD49d as an overall (OS) and treatment-free survival (TFS) predictor.
leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis
was performed using published and unpublished CLL series to evaluate the impact of
CD49d as an overall (OS) and treatment-free survival (TFS) predictor.
Abstract
Purpose
Although CD49d is an unfavorable prognostic marker in chronic lymphocytic leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis was performed using published and unpublished CLL series to evaluate the impact of CD49d as an overall (OS) and treatment-free survival (TFS) predictor.
ncbi.nlm.nih.gov
